Lung cancer drug combo test halted early – results still sought

NCT ID NCT06897579

Terminated Disease control Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Apr 15, 2026 · Last updated Apr 30, 2026 · Updated 2 times

Summary

This study tested two different drug combinations as a first treatment for people with extensive-stage small cell lung cancer, a fast-growing cancer that has spread. One group received a standard chemo plus bemarituzumab followed by bemarituzumab with anlotinib; the other got chemo plus tislelizumab followed by tislelizumab alone. The trial was stopped early, but researchers aimed to see which approach helped people live longer without the cancer getting worse.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Baotou Cancer Hospital

Baotou, Inner Mongolia, 014000, China
Beijing Cancer Hospital

Beijing, Beijing Municipality, 100142, China
Cancer Hospital Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, 100000, China
Cancer Hospital of Shantou University Medical College

Shantou, Guangdong, 510000, China
Dongyang Municipal People's Hospital

Dongyang, Zhejiang, 522031, China
Fujian Medical University 2nd Affiliated Hospital

Quanzhou, Fujian, 362001, China
Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University

Zhengzhou, Henan, 457000, China
Henan Provincial People'S Hospital

Zhengzhou, Henan, 450003, China
Huazhong University of Science and Technology Tongji Medical College of Huazhong University of Science and Technology

Wuhan, Hubei, 430000, China
Jiangsu Cancer Hospital

Nanjing, Jiangsu, 210009, China
Jingzhou Central Hospital

Jingzhou, Hubei, 434000, China
Liaoning Cancer Hospital & Institute

Shenyang, Liaoning, 110000, China
Linyi City People's Hospital

Linyi, Shandong, 276003, China
Maanshan People's Hospital

Maanshan, Anhui, 243000, China
Nanfang Hospital

Guangzhou, Guangzhou, 510515, China
Ningbo Medical Center Lihuili Hospital

Ningbo, Zhejiang, 315000, China
Ningbo No.2 Hospital

Ningbo, Zhejiang, 315010, China
Peking University People´s Hospital

Beijing, Beijing Municipality, 100044, China
Shanxi Cancer hospital

Taiyuan, Shanxi, 30000, China
Shenyang Tenth People's Hospital

Shenyang, Liaoning, 110044, China
Sichuan cancer hospital

Chengdu, Sichuan, 610042, China
Taizhou Hospital of Zhejiang Province

Taizhou, Zhejiang, 317000, China
Tangshan People's Hospital

Tangshan, Hebei, 063001, China
The First Affiliated Hospital of China Medical University

Shenyang, Liaoning, 110000, China
The First Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, 150000, China
The First Affiliated Hospital of Jinzhou Medical University

Jinzhou, Liaoning, 121001, China
The First Affiliated Hospital of Shandong First Medical University

Jinnan, Shandong, 250000, China
The Second Affiliated Hospital Of Xi'an Jiaotong University

Xi'an, Shannxi, 710000, China
The Second Hospitai. & Clinicae Medical School . Lanzhou University

Lanzhou, Gansu, 730030, China
The Second People's Hosital of Jiaozuo

Jiaozuo, Henan, 454001, China
The Second Xiangya Hospital of Central South University

Changsha, Hunan, 410011, China
The fourth hospital of hebei medical university

Shijiazhuang, Hebei, 05000, China

Conditions

Explore the condition pages connected to this study.

EXTENSIVE STAGE SMALL CELL LUNG CANCER EXTENSIVE-STAGE SMALL CELL LUNG CANCER